Optiver Holding
LENZ

Optiver Holding’s LENZ Therapeutics LENZ Stock Holding History

Optiver Holding’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3K Hold
142
– – ﹤0.01% 2002
2025
Q4 		$2.27K Hold
142
– – ﹤0.01% 1945
2025
Q3 		$6.61K Buy
+142
New +$5.22K ﹤0.01% 1538

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Optiver Holding's LENZ Position: Q1 2026 in Review

Optiver Holding held its LENZ Therapeutics (LENZ) position steady in Q1 2026 at 142 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Optiver Holding first reported a position in LENZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.61K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Optiver Holding held 142 shares of LENZ Therapeutics worth $1.3K as of Q1 2026.
  • Optiver Holding left its LENZ Therapeutics share count unchanged in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2002 holding.
  • Optiver Holding first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's LENZ Therapeutics position peaked at $6.61K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.